ArticleBMC infectious diseases2020

Development of a hexavalent recombinant protein vaccine adjuvanted with Montanide ISA 50 V and determination of its protective efficacy against acute toxoplasmosis.

Esra Atalay Şahar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.